Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Kaken Pharmaceutical Co., Ltd. KKPCF

Full chart Compare
Set alert

Price alert · KKPCF

All alert types
26.00 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

22.30 Day range 23.27
22.30 52-week range 28.12
YTD
+9.94%
1 year
+8.33%

Financial health

Altman Z-Score

4.88 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 71.7×
FY 2017: 7.6×FY 2018: 8.3×FY 2019: 9.2×FY 2020: 8.0×FY 2021: 11.7×FY 2022: 19.3×FY 2023: 26.8×FY 2024: 17.1×FY 2025: 10.8×FY 2026: 71.7×
FY 2017 5y median 19.3× FY 2026
P/S 2.0×
FY 2017: 1.6×FY 2018: 1.6×FY 2019: 1.7×FY 2020: 1.7×FY 2021: 2.1×FY 2022: 2.4×FY 2023: 2.0×FY 2024: 1.9×FY 2025: 1.6×FY 2026: 2.0×
FY 2017 5y median 2.0× FY 2026
P/B 1.1×
FY 2017: 1.6×FY 2018: 1.4×FY 2019: 1.3×FY 2020: 1.2×FY 2021: 1.2×FY 2022: 1.3×FY 2023: 1.1×FY 2024: 1.0×FY 2025: 1.0×FY 2026: 1.1×
FY 2017 5y median 1.1× FY 2026
P/FCF -11.0×
FY 2017: 13.0×FY 2018: 8.0×FY 2019: 8.6×FY 2020: 6.1×FY 2021: 13.0×FY 2022: 18.3×FY 2023: 20.7×FY 2024: 334×FY 2025: 5.9×FY 2026: -11.0×
FY 2017 5y median 18.3× FY 2026
EV/EBITDA 47.6×
FY 2017: 4.2×FY 2018: 3.9×FY 2019: 4.4×FY 2020: 3.4×FY 2021: 4.6×FY 2022: 7.7×FY 2023: 9.6×FY 2024: 7.2×FY 2025: 4.6×FY 2026: 47.6×
FY 2017 5y median 7.7× FY 2026
EV/Sales 1.5×
FY 2017: 1.4×FY 2018: 1.2×FY 2019: 1.3×FY 2020: 1.1×FY 2021: 1.3×FY 2022: 1.7×FY 2023: 1.2×FY 2024: 1.3×FY 2025: 1.1×FY 2026: 1.5×
FY 2017 5y median 1.3× FY 2026
FCF Yield -9.1%
FY 2017: 7.7%FY 2018: 12.5%FY 2019: 11.6%FY 2020: 16.3%FY 2021: 7.7%FY 2022: 5.5%FY 2023: 4.8%FY 2024: 0.3%FY 2025: 16.9%FY 2026: -9.1%
FY 2017 5y median 4.8% FY 2026

Profitability

Gross Margin 51.0%
FY 2017: 56.3%FY 2018: 56.9%FY 2019: 57.1%FY 2020: 56.6%FY 2021: 54.6%FY 2022: 54.7%FY 2023: 54.2%FY 2024: 53.5%FY 2025: 62.2%FY 2026: 51.0%
FY 2017 5y median 54.2% FY 2026
Operating Margin -1.2%
FY 2017: 30.1%FY 2018: 27.9%FY 2019: 26.1%FY 2020: 29.7%FY 2021: 23.7%FY 2022: 22.4%FY 2023: 11.0%FY 2024: 13.2%FY 2025: 22.4%FY 2026: -1.2%
FY 2017 5y median 13.2% FY 2026
Net Margin 2.8%
FY 2017: 21.6%FY 2018: 19.3%FY 2019: 18.9%FY 2020: 21.7%FY 2021: 17.9%FY 2022: 12.6%FY 2023: 7.5%FY 2024: 11.1%FY 2025: 14.8%FY 2026: 2.8%
FY 2017 5y median 11.1% FY 2026
ROE 1.5%
FY 2017: 21.4%FY 2018: 16.7%FY 2019: 14.7%FY 2020: 15.1%FY 2021: 9.8%FY 2022: 6.9%FY 2023: 4.0%FY 2024: 5.6%FY 2025: 9.1%FY 2026: 1.5%
FY 2017 5y median 5.6% FY 2026
ROIC -0.5%
FY 2017: 18.9%FY 2018: 16.4%FY 2019: 13.3%FY 2020: 13.8%FY 2021: 8.8%FY 2022: 7.8%FY 2023: 4.3%FY 2024: 5.0%FY 2025: 9.2%FY 2026: -0.5%
FY 2017 5y median 5.0% FY 2026
ROA 1.2%
FY 2017: 16.3%FY 2018: 12.5%FY 2019: 11.4%FY 2020: 12.3%FY 2021: 8.2%FY 2022: 5.8%FY 2023: 3.3%FY 2024: 4.7%FY 2025: 7.3%FY 2026: 1.2%
FY 2017 5y median 4.7% FY 2026

Growth (YoY)

Revenue -17.7%
FY 2017: -6.6%FY 2018: -3.5%FY 2019: -4.3%FY 2020: -5.2%FY 2021: -16.0%FY 2022: 1.4%FY 2023: -4.0%FY 2024: -1.3%FY 2025: 30.5%FY 2026: -17.7%
FY 2017 FY 2026
Operating Income -104.3%
FY 2017: -12.6%FY 2018: -10.5%FY 2019: -10.6%FY 2020: 7.8%FY 2021: -32.9%FY 2022: -4.1%FY 2023: -53.1%FY 2024: 18.9%FY 2025: 121.1%FY 2026: -104.3%
FY 2017 FY 2026
EPS (diluted) -84.3%
FY 2017: 5.1%FY 2018: -12.3%FY 2019: -5.3%FY 2020: 11.0%FY 2021: -29.8%FY 2022: -27.6%FY 2023: -42.4%FY 2024: 46.9%FY 2025: 71.8%FY 2026: -84.3%
FY 2017 FY 2026
Free Cash Flow -155.8%
FY 2017: -45.6%FY 2018: 52.7%FY 2019: -4.1%FY 2020: 33.0%FY 2021: -52.1%FY 2022: -16.7%FY 2023: -30.1%FY 2024: -94.2%FY 2025: 6092.2%FY 2026: -155.8%
FY 2017 FY 2026

Financial Health

Current Ratio 4.5×
FY 2017: 3.8×FY 2018: 3.3×FY 2019: 3.8×FY 2020: 5.0×FY 2021: 5.3×FY 2022: 5.8×FY 2023: 5.3×FY 2024: 5.6×FY 2025: 3.7×FY 2026: 4.5×
FY 2017 5y median 5.3× FY 2026
Quick Ratio 3.6×
FY 2017: 3.1×FY 2018: 2.8×FY 2019: 3.3×FY 2020: 4.4×FY 2021: 4.6×FY 2022: 5.0×FY 2023: 4.5×FY 2024: 4.7×FY 2025: 3.0×FY 2026: 3.6×
FY 2017 5y median 4.5× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA -17.0×
FY 2017: -0.9×FY 2018: -1.4×FY 2019: -1.6×FY 2020: -1.9×FY 2021: -2.9×FY 2022: -3.5×FY 2023: -5.9×FY 2024: -3.7×FY 2025: -2.3×FY 2026: -17.0×
FY 2017 5y median -3.7× FY 2026
Interest Coverage -20.0×
FY 2017: 1462×FY 2018: 1719×FY 2019: 1447×FY 2020: 1560×FY 2021: 1046×FY 2022: 1004×FY 2023: 470×FY 2024: 560×FY 2025: 751×FY 2026: -20.0×
FY 2017 5y median 560× FY 2026

Dividends

Dividend Yield 4.2%
FY 2017: 3.7%FY 2018: 3.8%FY 2019: 3.7%FY 2020: 3.8%FY 2021: 3.7%FY 2022: 3.1%FY 2023: 3.9%FY 2024: 4.1%FY 2025: 4.8%FY 2026: 4.2%
FY 2017 5y median 4.1% FY 2026
Payout Ratio 303.1%
FY 2017: 28.6%FY 2018: 32.0%FY 2019: 33.8%FY 2020: 30.4%FY 2021: 43.3%FY 2022: 59.8%FY 2023: 103.8%FY 2024: 70.5%FY 2025: 51.6%FY 2026: 303.1%
FY 2017 5y median 70.5% FY 2026

Annual · latest fiscal year ends 2026-03-31